|
|
|
|
|
|
|
 Solvay Pharmaceuticals is the global market leader and the largest manufacturer of pancreatic enzymes, with many years of experience in research and development in this field. The Creon® product range is used for the treatment of pancreatic exocrine insufficiency, associated with several underlying conditions, examples of which include cystic fibrosis, chronic pancreatitis and following pancreatic surgery.
With particular regard to cystic fibrosis patients, pancreatic enzymes are a cornerstone of their treatment. They help these patients to digest food and avoid malnutrition.
Creon® Minimicrospheres®
Our advanced formulation and manufacturing technology has resulted in an optimal size for the enteric coated microspheres in each Creon® capsule, known as Creon® Minimicrospheres®. Consequently it combines the features of fast, homogeneous distribution in the stomach with complete protection against inactivation by gastric juices. Creon® is designed to enable a simultaneous passage through the stomach and further into the duodenum together with the food, and a rapid release of the digestive pancreatic enzymes in the duodenum. Innovative research and development continues, offering patients real hope of further improvements in their quality of life. Creon is registered in more than 80 countries and helps thousands of patients worldwide.
|
|
|
|
|
|
